Literature DB >> 8709997

Measuring patients' ability to read and comprehend: a first step in patient education.

F L Wilson.   

Abstract

Recent reports released by the U.S. Department of Education indicate that approximately 90 million adults have poor reading and comprehension skills. This information highlights the importance of considering the literacy level of clients when planning patient education programs. The purpose of this investigation was to measure, in urban public clinics, the discrepancy between a self-report of the highest grade completed in school and the actual reading and comprehension levels of patients, measured by the WRAT and CLOZE. Twenty-five subjects, 22 African Americans and 3 Caucasians, participated in this study. The findings indicated that, even though the self-reported highest grade completed showed a mean of twelth grade, the actual mean reading level was below eighth grade. The results on comprehension showed that 52% (N = 13) of the subjects needed additional instructions after reading materials and 24% were unable to comprehend what they read. The demographics of people with poor literacy skills suggests that they represent a significant proportion of health care consumers who visit health departments, primary care facilities, and community-based health centers.

Entities:  

Mesh:

Year:  1995        PMID: 8709997

Source DB:  PubMed          Journal:  Nursingconnections        ISSN: 0895-2809


  3 in total

1.  Pharmaceutical company internet sites as sources of information about antidepressant medications.

Authors:  Mark A Graber; Michelle Weckmann
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Informing patients: a guide for providing patient health information.

Authors:  P C Tang; C Newcomb
Journal:  J Am Med Inform Assoc       Date:  1998 Nov-Dec       Impact factor: 4.497

3.  Effects of race and socioeconomic status on the relative influence of education and literacy on cognitive functioning.

Authors:  Vonetta M Dotson; Melissa H Kitner-Triolo; Michele K Evans; Alan B Zonderman
Journal:  J Int Neuropsychol Soc       Date:  2009-07       Impact factor: 2.892

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.